Akari Therapeutics PLC (AKTX)
1.48
+0.20
(+15.63%)
USD |
NASDAQ |
Apr 30, 16:00
1.48
0.00 (0.00%)
After-Hours: 17:22
Akari Therapeutics Market Cap: 11.73M for April 30, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
April 29, 2024 | 10.14M |
April 26, 2024 | 9.390M |
April 25, 2024 | 9.429M |
April 24, 2024 | 9.429M |
April 23, 2024 | 9.588M |
April 22, 2024 | 9.35M |
April 19, 2024 | 9.241M |
April 18, 2024 | 9.588M |
April 17, 2024 | 8.884M |
April 16, 2024 | 9.156M |
April 15, 2024 | 9.508M |
April 12, 2024 | 9.588M |
April 11, 2024 | 8.716M |
April 10, 2024 | 10.30M |
April 09, 2024 | 10.42M |
April 08, 2024 | 11.09M |
April 05, 2024 | 11.17M |
April 04, 2024 | 11.41M |
April 03, 2024 | 12.28M |
April 02, 2024 | 11.96M |
April 01, 2024 | 11.96M |
March 28, 2024 | 12.34M |
March 27, 2024 | 12.31M |
March 26, 2024 | 12.47M |
March 25, 2024 | 12.57M |
Date | Value |
---|---|
March 22, 2024 | 11.98M |
March 21, 2024 | 12.11M |
March 20, 2024 | 12.57M |
March 19, 2024 | 12.84M |
March 18, 2024 | 13.23M |
March 15, 2024 | 13.04M |
March 14, 2024 | 13.50M |
March 13, 2024 | 14.23M |
March 12, 2024 | 14.16M |
March 11, 2024 | 14.23M |
March 08, 2024 | 14.16M |
March 07, 2024 | 14.69M |
March 06, 2024 | 14.56M |
March 05, 2024 | 14.96M |
March 04, 2024 | 14.89M |
March 01, 2024 | 15.09M |
February 29, 2024 | 15.55M |
February 28, 2024 | 14.69M |
February 27, 2024 | 15.15M |
February 26, 2024 | 15.69M |
February 23, 2024 | 15.48M |
February 22, 2024 | 14.82M |
February 21, 2024 | 15.35M |
February 20, 2024 | 15.82M |
February 16, 2024 | 14.82M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
8.716M
Minimum
Apr 11 2024
149.28M
Maximum
Feb 19 2021
50.47M
Average
47.93M
Median
Market Cap Benchmarks
DBV Technologies SA | 132.72M |
Adaptimmune Therapeutics PLC | 293.72M |
Biodexa Pharmaceuticals Plc | 6.490M |
NuCana PLC | 8.310M |
Genfit SA | 174.51M |
Market Cap Related Metrics
Price | 1.48 |
Earnings Yield | -138.2% |